NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

NCT04267614

CompletedN/A

Sponsor: Pfizer

Conditions: Arthritis Rheumatoid

Interventions: Etanercept

Countries: Iraq

This study is to investigate the effect of etanercept in early versus delayed referral for management of rheumatoid arthritis patients assessing real-world patient data entered in the Iraq National Center of Rheumatology database between May 2012 and May 2017.

Eligibility overview

Sex: ALL

Age: 0 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosed RA patients.
* 18 years old and above.
* Did not receive pervious biological treatment.

Exclusion Criteria:

* Had previous biological treatment
* Use etanercept for less than 1 year

Locations (1)

Baghdad, Iraq